Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -14,667 | -12,649 | -14,857 | -4,620 |
| Depreciation Amortization | 233 | 174 | 5,615 | 1,010 |
| Accounts payable and accrued liabilities | 124 | 359 | 26 | N/A |
| Other Working Capital | 4,055 | -3,013 | -426 | 40 |
| Other Operating Activity | 1,024 | 3,943 | 3,425 | 1,450 |
| Operating Cash Flow | $-9,232 | $-11,186 | $-6,217 | $-2,120 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -255 | -619 | -259 | -170 |
| Other Investing Activity | 0 | 0 | 0 | -230 |
| Investing Cash Flow | $-255 | $-619 | $-259 | $-400 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 137 | 110 | 2,897 | N/A |
| Common Stock Issued | N/A | 21,154 | 5,346 | N/A |
| Other Financing Activity | -25 | 0 | -59 | 3,380 |
| Financing Cash Flow | $113 | $21,264 | $8,185 | $3,380 |
| Beginning Cash Position | 12,020 | 2,561 | 852 | 0 |
| End Cash Position | 2,646 | 12,020 | 2,561 | 850 |
| Net Cash Flow | $-9,374 | $9,459 | $1,709 | $850 |
| Free Cash Flow | ||||
| Operating Cash Flow | -9,232 | -11,186 | -6,217 | -2,120 |
| Capital Expenditure | -255 | -619 | -259 | N/A |
| Free Cash Flow | -9,487 | -11,805 | -6,476 | -2,120 |